-
Most Recent
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
If Novartis’ MS Drug Falters, Biogen Will Gain
After the deaths of 11 people who were taking the drug, concerns that Gilenya may cause heart problems has hit NVS hard, ending the stock's months-long upswing.
The Little Guys Are Pharma’s New Stars
Small and midsize drugmakers are where the action is -- in both research and M&A activity. For healthy dividends, however, Big Pharma still rules.
XLV Provides a Healthy Dose of Pfizer
If the health care sector is a must-have for your portfolio, and Pfizer is at the top of that list -- here's a way to get a healthier dose.
Despite Connecticut Change on Medicaid, Outlook Strong for Health Insurers
Connecticut recently dropped private insurers from serving its Medicaid members, but many of the industry's big names are far from worried.
Are Pharma’s ‘Good Old Days’ Gone Forever?
You bet they are: Patent losses, a higher bar for FDA approvals, and slew of smaller, nimbler rivals have reshaped the industry.
Novartis Cutting 2,000 Jobs – So Much for Healthy Healthcare Stocks!
Novartis NYSE:NVS is cutting nearly 2,000 jobs in the United States. The reason? Patent expiration for its blockbuster blood pressure drug Diovan.
Merck Is Shopping for Smarts In Hep C
The pharma giant says it's determined to be the leader in treatments for the disease -- a market that is expected to hit $20 billion by 2020.
8 Pharma Stocks in Good Health
The health care sector is a field that will continue to grow as Baby Boomers get old and retire. These eight companies will be at the center of this trend.
WebMD’s Business Model May Need Surgery
Big Pharma’s ad pullback and competition from social media have slammed the health-info site. In fact, the biggest threat to WebMD may be Facebook and Twitter.
Idenix and Achillion Jump on Takeover Talk
Their hepatitis C drugs could be lures for Big Pharma after a rival gets a juicy offer from Bristol-Myers Squibb.
WebMD Is Rushed to Emergency
Things seem to be getting worse for WebMD. The company not only has taken itself off the auction block, but its CEO has resigned. Result: a share price rout.
Where to Invest During the Last Stage of the Market Recovery
Add these stocks from the consumer staples, health care and utilities sectors during this final stage in the U.S. economy's recovery.
Top 5 Emerging Growth Stocks to Buy for January
The list of the top five emerging growth stocks to buy for January include tech and pharmaceutical companies -- as well as a "monster" beverage play.
Dendreon Jumps 40% on Provenge Sales
Dendreon saw its stock jump Thursday as sales of its cancer drug beat the expectations of both analysts and the company itself.
Teva’s New CEO Is Battle-Tested. Good Thing
Drug industry vet Jeremy Levin earned his stripes making deals for Bristol-Myers Squibb, but he'll face tough going at the generic-drug maker.
Mead Johnson Bounce Followed J&J Script
Mead Johnson's recent Enfamil scare sent many investors packing -- but those who stuck with the stock could soon be rewarded.
FDA, Insurers Demand Tests for New Drugs
Pressure on pharmaceutical companies for evidence that their drugs work is fueling a surge in the global market for "companion diagnostics."
New January Stock to Buy Is Almost Science Fiction
Intuitive Surgical's robotic surgery system is a hit that'll get hotter. The company's earnings and stock are set to soar in 2012.
